NIOSH alerts healthcare professionals to antineoplastic and other hazardous drugs in healthcare settings
From the National Institute for Occupational Safety and Health: "Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings," an approach to handling hazardous drugs safely.
The area of new drug development is evolving rapidly as unique approaches are being taken to treat cancer and other serious diseases.
The National Institute for Occupational Safety and Health (NIOSH) presents in its document “Preventing Occupational Exposure to Atineoplastic and Other Hazardous Drugs in Health Care Settings” a standard precautions or universal precautions approach to handling hazardous drugs safely. NIOSH recommends that all hazardous drugs be handled as outlined in this alert.
To access this document, go to http://www.cdc.gov/niosh/docs/2004-165/.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
